Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients with Coronavirus Disease-2019 during Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron Epoch

Raymund R. Razonable, John C. O’Horo, Sara N. Hanson, Richard F. Arndt, Leigh L. Speicher, Teresa A. Seville, Scott T. Hall, Marsha L. Pike, Alexander Heyliger, Jennifer J. Larsen, Ravindra Ganesh, Sidna M. Tulledge-Scheitel

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients with Coronavirus Disease-2019 during Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron Epoch'. Together they form a unique fingerprint.

Medicine & Life Sciences